Travere Therapeutics Ownership & Insider Activity

Travere Therapeutics (TVTX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.5% of shares outstanding. Institutional investors hold 73.3%. Over the past 90 days, insiders made 5 sales worth $28.2M.

Shares Outstanding

92.993M

Shares Float

71.116M

Insider Shares Owned

4.212M

Insider % Owned

4.5%

Institutional Shares Held

69.073M

Institutional % Held

73.3%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$28.2M total

Net Activity

Net Selling

Net Value (90d)

-$28.2M

Travere Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Oct 15, 2026	Eric Dube	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$32.98	$10.2M
Sep 15, 2026	WILLIAM ROTE	CHIEF RESEARCH OFFICER	SELL	17.548K	$42.12	$9.0M
Sep 15, 2026	Peter Heerma	EVP, CHIEF COMMERCIAL OFFICER	SELL	25.000K	$39.37	$13.8M
Sep 15, 2026	Jula Inrig	EVP, HEAD R&D & CMO	SELL	12.279K	$35.64	$2.5M
Sep 15, 2026	Elizabeth E Reed	CHIEF LEGAL OFFICER AND GC	SELL-OPTIONS	—	$38.90	$1.8M
Sep 15, 2026	Eric Dube	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$43.41	$16.1M
Sep 15, 2026	Christopher Cline	CHIEF FINANCIAL OFFICER	SELL	30.508K	$39.89	$2.8M
Sep 15, 2026	Sandra Calvin	SVP, CHIEF ACCOUNTING OFFICER	SELL-OPTIONS	—	$43.26	$205K
Sep 10, 2026	Jeffrey Meckler	—	SELL-OPTIONS	—	$44.64	$907K
Sep 2, 2026	Christopher Cline	CHIEF FINANCIAL OFFICER	SELL	642.000	$66.37	$43K
Aug 17, 2026	GARY LYONS	—	SELL-OPTIONS	—	$40.36	$458K
Jun 12, 2026	Timothy Coughlin	—	SELL-OPTIONS	—	$38.30	$236K
Jun 12, 2026	Roy Baynes	—	SELL-OPTIONS	—	$35.69	$129K
May 15, 2026	Timothy Coughlin	—	SELL	3.250K	$43.49	$141K
May 5, 2026	Roy Baynes	—	SELL-OPTIONS	—	$32.46	$128K
May 4, 2026	Jeffrey Meckler	—	SELL-OPTIONS	—	$30.66	$229K
May 4, 2026	WILLIAM ROTE	CHIEF RESEARCH OFFICER	SELL-OPTIONS	1.487K	$43.95	$121K
May 4, 2026	Elizabeth E Reed	CHIEF LEGAL OFFICER AND GC	SELL-OPTIONS	—	$31.51	$733K
May 4, 2026	Jula Inrig	CHIEF MEDICAL OFFICER	SELL-OPTIONS	1.765K	$33.77	$567K
May 4, 2026	Peter Heerma	CHIEF COMMERCIAL OFFICER	SELL-OPTIONS	2.076K	$46.65	$101K
May 4, 2026	Eric Dube	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$43.95	$989K
May 4, 2026	Christopher Cline	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	1.759K	$46.31	$115K

Travere Therapeutics Inc

Travere Therapeutics Ownership & Insider Activity

Travere Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch